Oncology

Relapsed/Refractory Multiple Myeloma

Advertisement

Expert Perspectives® in Relapsed/Refractory Multiple Myeloma to Cover Key Topics in Relapsed/Refractory Multiple Myeloma Treatment

expert perspectives by Ajai Chari, MD; Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; Robert Z. Orlowski, MD, PhD
Overview

Expert Perspectives® delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives® in Relapsed/Refractory Multiple Myeloma will feature community-selected experts and topics that we hope you will find of value in your clinical practice.


VIEW THE TOPICS:

 

Patient Care Perspectives

  • Improving Outcomes in Relapsed/Refractory Multiple Myeloma
  • The Patient Treatment Experience for Relapsed/Refractory Multiple Myeloma
  • The Role of Caregivers and Care Partners in Relapsed/Refractory Multiple Myeloma

 

Clinical Topic Updates

  • Later-Line Therapies for Relapsed/Refractory Multiple Myeloma
  • Mechanisms of Resistance in Relapsed/Refractory Multiple Myeloma
  • Treatment Beyond the Clinical Trial Setting for Relapsed/Refractory Multiple Myeloma

 

Expert Roundtables

  • Roundtables Podcast: Salvage Therapy After BCMA-Directed CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
  • Treatment Strategies for Triple-Class Refractory Multiple Myeloma

Ajai Chari, MD

Professor of Clinical Medicine
Director, Multiple Myeloma Program
UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, CA

Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO

Professor, Clinical Genomics and Therapeutics
Translational Genomics Research Institute (TGen)
City of Hope Comprehensive Cancer Center
Consultant Hematologist and Director, Myeloma Research
HonorHealth Research Institute
Scottsdale, AZ

Robert Z. Orlowski, MD, PhD

Director, Myeloma Section
Department of Lymphoma/Myeloma
Florence Maude Thomas Cancer Research Professor
Department of Experimental Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Advertisement